Please use this identifier to cite or link to this item:
|Title:||Deciphering the biochemistry and identifying biomarkers to multiple sclerosis|
Farias, Alessandro S.
|Abstract:||Multiple sclerosis is an idiopathic demyelinating disease of the CNS. Despite being extensively studied during the last decades, many molecular aspects of the disease are still to be elucidated. Moreover, biomarkers for treatment and early diagnosis are major issues to be tackled. In this edition of Kroksveen et al. (Proteomics 2015, 15, 3361-3369) present biomarker candidates for the early detection of multiple sclerosis. Despite the need for validation in larger sets of samples, this dataset contributes to resolve open questions associated to multiple sclerosis.|
Multiple sclerosis is an idiopathic demyelinating disease of the CNS. Despite being extensivelystudied during the last decades, many molecular aspects of the disease are still to be elucidated.Moreover, biomarkers for treatment and early diagnosis are maj
|Editor:||John Wiley & Sons|
|Citation:||Proteomics. v. 15, n. 19, p. 3281-3282, 2015-Oct.|
|Appears in Collections:||IB - Artigos e Outros Documentos|
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.